Axumin ((18)F-Fluciclovine) PET imaging in men exhibiting no clinically significant cancer on initial negative biopsy of PI-RADS 4 and 5 regions of interest

PURPOSE: The objective of the study was to determine whether Axumin ((18)F-Fluciclovine) PET/MRI informs the decision to perform an early repeat biopsy of PI-RADS 4/5 region of interest (ROI) exhibiting no clinically significant prostate cancer (csPCa) on initial biopsy. METHODS: This prospective st...

Descripción completa

Detalles Bibliográficos
Autores principales: Becher, Ezequiel, Karls, Shawn, Tong, Angela, Wysock, James S., Taneja, Samir S., Huang, William C., Lepor, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532230/
https://www.ncbi.nlm.nih.gov/pubmed/36197506
http://dx.doi.org/10.1007/s00345-022-04172-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532230/
https://www.ncbi.nlm.nih.gov/pubmed/36197506
http://dx.doi.org/10.1007/s00345-022-04172-3

Ejemplares similares